Yaron Werber
Stock Analyst at TD Cowen
(2.19)
# 2,838
Out of 5,130 analysts
44
Total ratings
40.62%
Success rate
0.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Initiates: Buy | n/a | $33.62 | - | 1 | Dec 18, 2025 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $13.52 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $22.51 | +233.19% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $44.04 | +15.80% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $788.49 | +45.34% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $80.30 | +23.29% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $1.86 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.56 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $337.89 | -1.15% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $23.88 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $38.19 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $25.30 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $202.99 | -24.63% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $99.85 | +22.18% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $29.75 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $23.60 | +183.90% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.85 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.51 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.66 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $27.38 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.48 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.13 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $34.26 | +10.92% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.98 | - | 1 | Oct 26, 2021 |
RAPT Therapeutics
Dec 18, 2025
Initiates: Buy
Price Target: n/a
Current: $33.62
Upside: -
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $13.52
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $22.51
Upside: +233.19%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $44.04
Upside: +15.80%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $788.49
Upside: +45.34%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $80.30
Upside: +23.29%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.86
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.56
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $337.89
Upside: -1.15%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $23.88
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $38.19
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $25.30
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $202.99
Upside: -24.63%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $99.85
Upside: +22.18%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $29.75
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $23.60
Upside: +183.90%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $32.85
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.51
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.66
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $27.38
Upside: -
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.48
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $7.13
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $34.26
Upside: +10.92%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $21.98
Upside: -